Document is current
Any future updates will be listed below
-
Authors
Wang, Ruoting
Liu, Yingxin
Thabane, Lehana
Olier, Ivan
Li, Likang
Ortega-Martorell, Sandra
Lip, Gregory Y.H.
Li, Guowei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82103906)
Science Foundation of Guangdong Second Provincial General Hospital (YY2018-002)
- License Information
-
More Information
Article History
Received: 5 January 2023
Accepted: 30 January 2024
First Online: 2 February 2024
Declarations
:
: The UK Biobank study was approved by the North West Multicenter Research Ethics Committee. All participants provided written consent before enrolment.
: Not applicable.
: GYHL has served as a consultant and speaker for Medtronic, BMS/Pfizer, Boehringer Ingelheim, Anthos and Daiichi-Sankyo. No fees have been received directly or personally. GYHL is co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899871. All other authors have declared no conflicts of interest.
